CNBC's Jim Cramer on Friday walked investors through another busy week in the thick of earnings season. He highlighted reports from tech titans Apple, Amazon, Microsoft and Meta as well as the release ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its ...

Bristol Myers Squibb’s new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of ...

"European price controls and austerity measures reduce the attractiveness of its markets," Novartis CEO Vas Narasimhan and ...

Next on the list of largest golden parachutes is Gilead’s Daniel O’Day, who would receive $80.6 million in the event of ...

UnitedHealth's new security spending disclosures underscore how a fatal shooting in December caused companies to reassess the ...

Numerous companies have unveiled investments in U.S. manufacturing in recent weeks, including TSMC, Eli Lilly, Hyundai Motor ...

The company also paid $207,931 on behalf of certain family members of the executives to provide them with personal and home ...

Chief Executive magazine announced April 7 that Dave Ricks, chair and CEO of Eli Lilly and Company, has been named 2025 Chief Executive of the Year. Ricks is the newest member of the Purdue ...

Eli Lilly is getting closer to bringing a weight loss pill to market, but CEO David Ricks notes certain factors need to be considered to prevent prices from ballooning.